The SpaceX IPO Is Coming. These Are the 3 Most Important Numbers From Its S-1 Filing

SpaceX is projected to begin trading on Nasdaq on June 12 with an implied valuation around $1.5 trillion or higher. The filing highlights a $28.5 trillion TAM, but also shows $8.6 billion in R&D spending in 2025, a $41.3 billion accumulated deficit, and a $4.3 billion net loss on $4.7 billion of revenue in Q1 2026. The article argues the IPO may be highly priced relative to still-weak profitability, making it a cautious early-stage investment proposition.

Analysis

The IPO is likely to create a short-term liquidity event more than a clean fundamental entry point. When a private asset comes public at a near-vanity valuation, the first-order trade is usually momentum and index-chasing; the second-order trade is whether the market becomes willing to underwrite years of capital intensity without visible FCF. That setup often benefits incumbents with cleaner earnings paths before the new issue can season.

The biggest overlooked winner is not the company itself, but adjacent enablers with visible AI capex leverage. If the firm’s spend is truly skewing toward AI, the cash burn will flow into a concentrated vendor base, which tends to favor the most strategically embedded compute, networking, and semicap names while the market debates the IPO price. This is especially true if public-market scrutiny forces management to prioritize “AI narrative” spending over more diffuse growth projects.

The main risk is that the stock trades like a perpetual growth option with no near-term fundamental backstop. In the first days to weeks, scarcity can overpower valuation, but over 3-6 months the market will anchor on burn rate, dilution cadence, and whether the AI opportunity converts into margin rather than just TAM. If rate-cut expectations fade or long-duration growth multiples compress, the premium could de-rate quickly even without any company-specific disappointment.

Consensus is probably underestimating how much the IPO could be a sentiment read-through for the broader “AI at any price” basket. If this deal clears at an extreme multiple and trades well, it validates aggressive underwriting for other pre-profit AI infrastructure names; if it stalls, the reset could hit the highest-duration beneficiaries first. The asymmetry is that the trade is more relevant as a signal for factor rotation than as a standalone single-name long on day one.

Key Decisions for Investors

• Avoid chasing the IPO in the first 1-2 weeks post-listing; wait for lockup/earnings-style price discovery before initiating any long, since the downside on multiple compression is asymmetric if sentiment cools.
• Long NVDA vs. short TSLA on a 1-3 month horizon as a cleaner expression of AI capex monetization versus balance-sheet-heavy optionality; risk/reward improves if the IPO opens at a premium valuation and then normalizes.
• Add a tactical long in NVDA on any post-IPO weakness in AI infrastructure names; the likely second-order effect is capital rotation into the most proven AI picks-and-shovels exposure.
• For more conservative exposure, buy a call spread in NVDA or INTC over the next 2-4 months to capture possible spillover from AI spend enthusiasm while limiting valuation risk if the IPO underwhelms.
• If the stock trades sharply above issue price in week 1, consider a short-dated put spread against the IPO name once borrow/liquidity permit, targeting a 15-20% retracement as the first realistic mean-reversion band.